Literature DB >> 25925389

Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.

Line Kenborg, Christina F Lassen, Beate Ritz, Klaus K Andersen, Jane Christensen, Eva S Schernhammer, Johnni Hansen, Lene Wermuth, Naja H Rod, Jørgen H Olsen.   

Abstract

The relationship between Parkinson disease (PD) and smoking has been examined in several studies, but little is known about smoking in conjunction with other behaviors and a family history of PD. Using unconditional logistic regression analysis, we studied individual and joint associations of these factors with idiopathic PD among 1,808 Danish patients who were diagnosed in 1996-2009 and matched to 1,876 randomly selected population controls. Although there was a downward trend in duration of smoking, this was not observed for daily tobacco consumption. A moderate intake of caffeine (3.1-5 cups/day) was associated with a lower odds ratio for PD (0.45, 95% confidence interval: 0.34, 0.62), as was a moderate intake of alcohol (3.1-7 units/week) (odds ratio = 0.60, 95% confidence interval: 0.58, 0.84); a higher daily intake did not reduce the odds further. When these behaviors were studied in combination with smoking, the odds ratios were lower than those for each one alone. Compared with never smokers with no family history of PD, never smokers who did have a family history had an odds ratio of 2.81 (95% confidence interval: 1.91, 4.13); for smokers with a family history, the odds ratio was 1.60 (95% confidence interval: 1.15, 2.23). In conclusion, duration of smoking seems to be more important than intensity in the relationship between smoking and idiopathic PD. The finding of lower risk estimates for smoking in combination with caffeine or alcohol requires further confirmation.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson disease; alcohol drinking; caffeine; case-control study; lifestyle; smoking

Mesh:

Substances:

Year:  2015        PMID: 25925389      PMCID: PMC4423523          DOI: 10.1093/aje/kwu332

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  Risk factors for parkinson's disease: the leisure world cohort study.

Authors:  A Paganini-Hill
Journal:  Neuroepidemiology       Date:  2001-05       Impact factor: 3.282

2.  Validity of family history data on PD: evidence for a family information bias.

Authors:  A Elbaz; S K McDonnell; D M Maraganore; K J Strain; D J Schaid; J H Bower; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

3.  Validation of hospital register-based diagnosis of Parkinson's disease.

Authors:  Lene Wermuth; Christina Funch Lassen; Liselotte Himmerslev; Jørgen Olsen; Beate Ritz
Journal:  Dan Med J       Date:  2012-03       Impact factor: 1.240

4.  Caffeine intake, smoking, and risk of Parkinson disease in men and women.

Authors:  Rui Liu; Xuguang Guo; Yikyung Park; Xuemei Huang; Rashmi Sinha; Neal D Freedman; Albert R Hollenbeck; Aaron Blair; Honglei Chen
Journal:  Am J Epidemiol       Date:  2012-04-13       Impact factor: 4.897

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  A family history of Parkinson's disease and its effect on other PD risk factors.

Authors:  B A Rybicki; C C Johnson; E L Peterson; G X Kortsha; J M Gorell
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

Review 7.  Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease.

Authors:  G W Ross; H Petrovitch
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

8.  Alcohol consumption and the incidence of Parkinson's disease.

Authors:  Miguel A Hernán; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

9.  Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies.

Authors:  Dongfeng Zhang; Hong Jiang; Junxia Xie
Journal:  Mov Disord       Date:  2014-03-03       Impact factor: 10.338

10.  Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.

Authors:  W Hellenbrand; A Seidler; H Boeing; B P Robra; P Vieregge; P Nischan; J Joerg; W H Oertel; E Schneider; G Ulm
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  11 in total

1.  Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.

Authors:  Yu-Hsuan Chuang; Christina M Lill; Pei-Chen Lee; Johnni Hansen; Christina F Lassen; Lars Bertram; Naomi Greene; Janet S Sinsheimer; Beate Ritz
Journal:  Neuroepidemiology       Date:  2016-01-31       Impact factor: 3.282

2.  Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease.

Authors:  Yu-Hsuan Chuang; Pei-Chen Lee; Tim Vlaar; Claire Mulot; Marie-Anne Loriot; Johnni Hansen; Christina M Lill; Beate Ritz; Alexis Elbaz
Journal:  Ann Neurol       Date:  2017-10-26       Impact factor: 10.422

3.  Cancers Preceding Parkinson's Disease after Adjustment for Bias in a Danish Population-Based Case-Control Study.

Authors:  Xin Cui; Zeyan Liew; Johnni Hansen; Pei-Chen Lee; Onyebuchi A Arah; Beate Ritz
Journal:  Neuroepidemiology       Date:  2019-01-18       Impact factor: 3.282

Review 4.  Nicotine from cigarette smoking and diet and Parkinson disease: a review.

Authors:  Chaoran Ma; Yesong Liu; Samantha Neumann; Xiang Gao
Journal:  Transl Neurodegener       Date:  2017-07-02       Impact factor: 8.014

5.  Nicotine promotes neuron survival and partially protects from Parkinson's disease by suppressing SIRT6.

Authors:  Justin W Nicholatos; Adam B Francisco; Carolyn A Bender; Tiffany Yeh; Fraz J Lugay; Jairo E Salazar; Christin Glorioso; Sergiy Libert
Journal:  Acta Neuropathol Commun       Date:  2018-11-08       Impact factor: 7.801

Review 6.  Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review.

Authors:  Amnon A Berger; Ariel Winnick; Alexandra Welschmeyer; Alicia Kaneb; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2020-12-08

Review 7.  Epidemiology of Parkinson's Disease-East Versus West.

Authors:  Masoom M Abbas; Zheyu Xu; Louis C S Tan
Journal:  Mov Disord Clin Pract       Date:  2017-12-22

8.  Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.

Authors:  Hanan Khalil; Lana M Chahine; Junaid Siddiqui; Mehri Salari; Shaimaa El-Jaafary; Zakiyah Aldaajani; Mishal Abu Al-Melh; Tareq Mohammad Mohammad; Muneer Abu Snineh; Nadir A Syed; Mohit Bhatt; Mohammad Ahsan Habib; Majed Habahbeh; Samer D Tabbal; Beomseok Jeon; Jawad A Bajwa
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Iatrogeny of Alzheimer's disease: A view point.

Authors:  Manu Kothari; Lopa Mehta
Journal:  J Craniovertebr Junction Spine       Date:  2016 Jan-Mar

Review 10.  The associations between Parkinson's disease and cancer: the plot thickens.

Authors:  Danielle D Feng; Waijiao Cai; Xiqun Chen
Journal:  Transl Neurodegener       Date:  2015-10-26       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.